Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202) : a multicentre, randomised, parallel-group, open-label, phase 2 trial

Wedemeyer, Heiner; Schoeneweis, Katrin; Bogomolov, Pavel; Blank, Antje; Voronkova, Natalia; Stepanova, Tatiana; Sagalova, Olga; Chulanov, Vladimir; Osipenko, Marina; Morozov, Viacheslav; Geyvandova, Natalia; Sleptsova, Snezhana; Bakulin, Igor G.; Khaertynova, Ilsiyar; Rusanova, Marina; Pathil, Anita; Merle, Uta; Bremer, Birgit; Allweiss, Lena; Lempp, Florian A.; Port, Kerstin; Haag, Mathias; Schwab, Matthias; Wiesch, Julian Schulze zur; Cornberg, Markus; Haefeli, Walter E.; Dandri, Maura; Alexandrov, Alexander; Urban, Stephan

Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202) : a multicentre, randomised, parallel-group, open-label, phase 2 trial

Autor(en):

Wedemeyer, Heiner; Schoeneweis, Katrin; Bogomolov, Pavel; Blank, Antje; Voronkova, Natalia; Stepanova, Tatiana; Sagalova, Olga; Chulanov, Vladimir; Osipenko, Marina; Morozov, Viacheslav; Geyvandova, Natalia; Sleptsova, Snezhana; Bakulin, Igor G.; Khaertynova, Ilsiyar; Rusanova, Marina; Pathil, Anita; Merle, Uta; Bremer, Birgit; Allweiss, Lena; Lempp, Florian A.; Port, Kerstin; Haag, Mathias; Schwab, Matthias; Wiesch, Julian Schulze zur; Cornberg, Markus; Haefeli, Walter E.; Dandri, Maura; Alexandrov, Alexander; Urban, Stephan

Tübinger Autor(en):

Haag, Mathias
Schwab, Matthias

Erschienen in:

Lancet Infectious Diseases (2023), Bd. 23, H. 1, S. 117-129

Verlagsangabe:

Elsevier Sci Ltd

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/S1473-3099(22)00318-8

ISSN:

1473-3099